AbCellera Biologics Inc.ABCLNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank29
3Y CAGR+31.7%
5Y CAGR-21.7%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+31.7%/yr
vs -72.3%/yr prior
5Y CAGR
-21.7%/yr
Recent acceleration
Acceleration
+104.0pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 13.60 | -54.5% |
| 2024 | 29.91 | -31.1% |
| 2023 | 43.42 | +630.0% |
| 2022 | 5.95 | -43.4% |
| 2021 | 10.51 | -77.3% |
| 2020 | 46.22 | -95.8% |
| 2019 | 1092.66 | +8.4% |
| 2018 | 1007.55 | - |